![](https://assets.isu.pub/document-structure/210208045001-726b3426c814fa74903c29ab9a59e281/v1/8a2065aead8b9741f56165837d4f4cb5.jpg?width=720&quality=85%2C50)
2 minute read
Industry Partners Program Committee
by SCDesign
The Industry Partners Program (IPP) identifies and creates opportunities to engage CBNS research with industry and commercial stakeholders. The program recognises the diverse opportunities available to Centre members within and outside academia and explores methods to engage and showcase CBNS activities to end-users of bio-nano science and technology.
The committee is chaired by CBNS CI Professor Kris Thurecht (UQ) and includes members from all nodes, including a PhD candidate and a Postdoctorate researcher.
Advertisement
The committee was created in June 2019 and met quarterly to discuss and coordinate industry engagement activities, build networks, expand the mentoring program and support ongoing relationships and communication with industry and end-users.
IPP Industry Workshop
The IPP Committee held their first activity, an industry workshop, in November 2019. The workshop objectives revolved around discussing some of the challenges and the opportunities of working in, and with industry and how to pursue a career in industry. Speakers were invited to talk about building successful research, careers and networks. CBNS was fortunate to have speakers from BioCurate, CSIRO, IP Australia, Pfizer and Starpharma representing industry, academia and government. Speakers enlightened members with their own diverse career stories. Held at Monash, the workshop drew CBNS members from all five nodes.
![](https://assets.isu.pub/document-structure/210208045001-726b3426c814fa74903c29ab9a59e281/v1/d359160138d526c0b2647ce0ce28ffb2.jpg?width=720&quality=85%2C50)
![](https://assets.isu.pub/document-structure/210208045001-726b3426c814fa74903c29ab9a59e281/v1/1e59bd53a1a69ad7b526c40ae05e0d32.jpg?width=720&quality=85%2C50)
The purpose of the Translation Strategy is to outline pathways for promoting CBNS research and translation efforts, and identify potential routes for implementation of research outcomes. The Industry Collaboration Toolkit provides research staff and students with avenues to explore the process for creating collaborations with pharmaceutical industry companies, academia and government, tapping into the resources and contacts available at each of the CBNS nodes.
IPP Translation Strategy
Stage 1:
Research
What is your research? Start with the fundamental research Build on foundations with applied research Stage 2:
Technology discovery
Is your research innovative? Must be new, inventive and useful Define the core opportunity Complete an invention disclosure form
Stage 4:
Build the asset/Product development
Have you developed your research to meet marketing requirements? Secure the IP (e.g. patent) Development plan, marketing plan and materials Commercialisation strategy and protection strategy Stage 3:
Assessment
Have you defined the value of your research in the market? Intellectual property position • Prior disclosure • Ownership Establish market opportunity in a competitive landscape Understand the value proposition Identify funding assistance opportunities
Stage 5:
Approach industry
What is your pitch to industry? On-going marketing Identify and discuss with potential partners Stage 6:
Secure the deal
Have you started negotiations to formalise an agreement? Negotiations and draft agreement Execute the deal – start up, licence, option, or assignment
Stage 7:
Post deal
Have you defined milestones and distribution of revenue? Establish research and commercial milestones Agreement compliance Commercialisation revenue distribution